Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global artificial organs market was valued at USD 19.91 Billion in 2025. It is poised to grow at a CAGR of 6.80% during the forecast period of 2026-2035, and reach USD 38.44 Billion by 2035. The market growth is driven by the rising organ failure prevalence, limited donor availability, and advancements in surgical procedures, boosting demand for artificial organs, while supportive regulations and healthcare investments are driving adoption and market growth globally.
Base Year
Historical Period
Forecast Period
In January 2026, ARPA‑H awarded grants under PRINT to develop universally matched 3D bioprinted organs, reducing donor dependency.
In January 2026, UC San Diego began 3D bioprinting patient specific livers, funded by ARPA H, offering a scalable organ transplant alternative.
According to the 2024 Global Observatory on Donation and Transplantation (GODT) report published through PubMed, a record 173,727 solid organ transplants were performed worldwide in 2024, the highest number ever reported globally.
Compound Annual Growth Rate
6.8%
Value in USD Billion
2026-2035
*this image is indicative*
The market is expanding due to increasing organ failure and limited donor availability. Rising organ failure and limited donor availability are driving innovation in artificial organs. Advances in medical technology, improved surgical procedures, and growing healthcare investments are enhancing patient care. Increasing awareness of transplant alternatives and supportive regulatory frameworks encourage adoption. Innovations in treatment devices and focus on personalized healthcare are expected to sustain growth and improve clinical outcomes globally during the forecast period. The market reached a value of approximately USD 19.91 Billion in 2025.
Government-Funded 3D Bioprinting Initiatives Boost the Market Value
Rising organ failure prevalence and limited donor availability are accelerating the adoption of innovative technologies in regenerative medicine. For instance, in January 2026, the U.S. Advanced Research Projects Agency for Health (ARPA H) awarded grants under its PRINT program to develop universally matched, on demand organs. By leveraging 3D bioprinting organs, this initiative aims to reduce transplant waitlists and reliance on donors. Such investments are expected to accelerate development of artificial organ solutions and expand market opportunities during the forecast period.
Key trends shaping the market include advanced 3D bioprinting, regenerative medicine, organ-on-chip technology, AI integration, and rising transplant demand.
Growing Innovative Bioprinting Projects Propel Market Expansion
Rising organ failure cases and increasing demand for transplant alternatives are driving innovation in organ engineering. For instance, in January 2026, a USD 25.8 million initiative led by UC San Diego, funded by ARPA H, began developing patient-specific, 3D bioprinted livers. This research offers a scalable organ transplant alternative, reducing dependence on donor organs and lifelong immunosuppression. The project is expected to accelerate the adoption of artificial organ technologies and expand market growth during the forecast period.
Market Breakup by Classification
Market Breakup by Type
Market Breakup by Technology
Market Breakup by Fixation
Market Breakup by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Mechanical Likely to Lead the Market Segment by Technology
The mechanical segment dominated the market by technology, accounting for over 66% of revenue in the historical period. Rising prevalence of organ failure and technological innovation are driving adoption of devices such as ventricular assist devices (VADs) and artificial hearts. Advances in patient care, improved surgical outcomes, and increasing awareness of organ transplant alternatives are expected to support the segment’s continued leadership throughout the forecast period.
North America held a dominant market share of above 44% in the historical period, supported by advanced healthcare infrastructure and strong investment in medical research. Adoption of innovative solutions like bioartificial kidneys and cochlear implants is rising. Regulatory support, reimbursement policies, and the growing focus on improving patient outcomes are driving market growth in the region, reinforcing North America’s position as a leading hub for artificial organ technologies globally.
The key features of the market report comprise strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 2001 and headquartered in Tucson, Arizona, SynCardia Systems, LLC is a leading medical device company that pioneers total artificial heart solutions for patients with end-stage heart failure. SynCardia’s flagship product, the Total Artificial Heart, has been commercially approved by regulators including the FDA and Health Canada and is used as a bridge to transplant. Ongoing innovations include fully implantable heart technologies and expanded clinical programs.
Berlin Heart GmbH, headquartered in Berlin, Germany, was established to develop and produce advanced mechanical circulatory support systems, particularly ventricular assist devices that support heart function for patients with severe heart failure. Its products, such as the EXCOR® VAD systems, serve newborns, children, and adults, with global reach and technical support. The company continues R&D investments to enhance device efficiency and patient outcomes.
Carmat SA is a French biomedical company focused on designing and developing next-generation total artificial heart technologies for patients with advanced biventricular heart failure. The company has expanded the clinical use of its Aeson® artificial heart, with commercial implants performed outside the EU and ongoing research to improve device performance and accessibility. Its innovations aim to offer durable transplant alternatives for patients with limited donor options.
Headquartered in Sydney, Australia, and founded in 1981, Cochlear Ltd. is a global leader in implantable hearing solutions. The company designs and manufactures cochlear implant systems and related technologies that restore auditory function for individuals with hearing loss. With a presence in over 180 countries, Cochlear focuses on R&D and strategic acquisitions to advance implant performance and accessibility, supporting improved quality of life for patients worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are B. Braun Melsungen AG, and others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Classification |
|
| Breakup by Type |
|
| Breakup by Technology |
|
| Breakup by Method of Fixation |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share